JPS5579321A - Medical composition for local administration - Google Patents

Medical composition for local administration

Info

Publication number
JPS5579321A
JPS5579321A JP15645879A JP15645879A JPS5579321A JP S5579321 A JPS5579321 A JP S5579321A JP 15645879 A JP15645879 A JP 15645879A JP 15645879 A JP15645879 A JP 15645879A JP S5579321 A JPS5579321 A JP S5579321A
Authority
JP
Japan
Prior art keywords
local administration
medical composition
medical
composition
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15645879A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6348849B2 (enExample
Inventor
Ruukasu Bofumiru
Buiizendanga Waruta
Haintsu Shiyumitsuto Rut Kaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS5579321A publication Critical patent/JPS5579321A/ja
Publication of JPS6348849B2 publication Critical patent/JPS6348849B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP15645879A 1978-12-04 1979-12-04 Medical composition for local administration Granted JPS5579321A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1236078 1978-12-04

Publications (2)

Publication Number Publication Date
JPS5579321A true JPS5579321A (en) 1980-06-14
JPS6348849B2 JPS6348849B2 (enExample) 1988-09-30

Family

ID=4382297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15645879A Granted JPS5579321A (en) 1978-12-04 1979-12-04 Medical composition for local administration

Country Status (9)

Country Link
EP (1) EP0012115A1 (enExample)
JP (1) JPS5579321A (enExample)
AU (1) AU531882B2 (enExample)
CA (1) CA1146859A (enExample)
IT (1) IT1164070B (enExample)
LU (1) LU81944A1 (enExample)
NZ (1) NZ192294A (enExample)
SE (1) SE448604B (enExample)
ZA (1) ZA796549B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208217A (ja) * 1982-02-03 1983-12-03 スコッティア　ホウルディングズ　ピーエルシー 局所性製薬組成物
JPH0640410U (ja) * 1992-10-31 1994-05-31 株式会社ミヨシ パワーショベル等の油圧回路
JP2010070571A (ja) * 2001-06-05 2010-04-02 Jeffrey B Smith 抗ウイルス用の亜鉛含有組成物
JP2014511851A (ja) * 2011-04-04 2014-05-19 コロプラスト アクティーゼルスカブ 接着パッチ

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
DE3273138D1 (en) * 1981-06-02 1986-10-16 Eupan Corp Eustatic composition for nonspecifically facilitating and amplifying the generalized homeostatic regulation and maintenance, compensation and repair in living organisms
GB2141929B (en) * 1983-06-16 1986-12-17 Victoria State Treatment of footrot
US4661354A (en) * 1984-06-21 1987-04-28 Finnerty Edmund F Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
CA1327354C (en) * 1987-03-19 1994-03-01 David Cullis-Hill Anti-inflamatory compounds and compositions
EP0285357A3 (en) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Control of retroviruses
EP0410002B1 (en) * 1989-02-10 1995-11-22 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug
US5624675A (en) * 1989-06-06 1997-04-29 Kelly; Patrick D. Genital lubricants containing zinc salts to reduce risk of HIV infection
EP0402078A3 (en) * 1989-06-06 1991-07-31 Patrick Daniel Kelly Sexual lubricants containing zinc as an anti-viral agent
DE4200499A1 (de) * 1992-01-10 1993-07-15 Bode Chemie Gmbh & Co Desinfektionsmittel
GB9521805D0 (en) * 1995-10-25 1996-01-03 Cortecs Ltd Solubilisation methods
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
EP2283805A1 (en) 2009-07-28 2011-02-16 Sirvis BV Compositions comprising a zinc containing compound dissolved in a hydrophobic phase
EP3791884A1 (en) 2019-09-16 2021-03-17 Oskar Bunz Combination of heparin and magnesium salt for the treatment of viral infections

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6225126A (ja) * 1985-07-25 1987-02-03 Matsushita Electric Works Ltd 付加型イミド樹脂積層板

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77562A1 (de) * 1977-06-17 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von neuen pharmazeutischen praeparaten

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6225126A (ja) * 1985-07-25 1987-02-03 Matsushita Electric Works Ltd 付加型イミド樹脂積層板

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208217A (ja) * 1982-02-03 1983-12-03 スコッティア　ホウルディングズ　ピーエルシー 局所性製薬組成物
JPH0640410U (ja) * 1992-10-31 1994-05-31 株式会社ミヨシ パワーショベル等の油圧回路
JP2010070571A (ja) * 2001-06-05 2010-04-02 Jeffrey B Smith 抗ウイルス用の亜鉛含有組成物
JP2014511851A (ja) * 2011-04-04 2014-05-19 コロプラスト アクティーゼルスカブ 接着パッチ

Also Published As

Publication number Publication date
CA1146859A (en) 1983-05-24
EP0012115A1 (de) 1980-06-11
SE448604B (sv) 1987-03-09
LU81944A1 (de) 1980-07-01
IT7950953A0 (it) 1979-11-30
ZA796549B (en) 1980-11-26
AU531882B2 (en) 1983-09-08
AU5337979A (en) 1980-06-12
NZ192294A (en) 1982-05-31
JPS6348849B2 (enExample) 1988-09-30
SE7909952L (sv) 1980-06-05
IT1164070B (it) 1987-04-08

Similar Documents

Publication Publication Date Title
GB2039738B (en) Inflammation - preventing pharmaceutical composition
GB2085732B (en) Administration set
JPS5283916A (en) Medical composition for aural administration
JPS52151712A (en) Composition for medical preparation
JPS54132223A (en) Novel pharmaceutical composition
JPS5528986A (en) Novel administration form
JPS5579321A (en) Medical composition for local administration
JPS5598110A (en) Local administration composition
GB2037781B (en) Blends for medical devices
ZA787000B (en) Pharmaceutical formulation
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
JPS54157817A (en) Pharmaceutical prepared solution
JPS5579388A (en) Medical composition containing amoxicillin
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
ZA793923B (en) Medicinal formulation
GB2034587B (en) Pharmaceutical compositions
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
JPS5535086A (en) Thazine derivative and medical composition
JPS54154516A (en) Pharmaceutical composition
JPS5527168A (en) Drug composition
JPS5562015A (en) Hypotensive medical composition
JPS5540677A (en) Medical composition
ZA793928B (en) Medicinal formulation